Evidence map›Paper›PMID 17855387›Full record

ArticleJournal of cell science2007

Cdc42 is required for EGF-stimulated protrusion and motility in MTLn3 carcinoma cells.

Mirvat El-Sibai, Peri Nalbant, Huan Pang, Rory J Flinn, Corina Sarmiento, Frank Macaluso, Michael Cammer, John S Condeelis, Klaus M Hahn, Jonathan M Backer

Open access · greenAbstract read
In one paragraph

Article in Journal of cell science, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Decoding Rho GTPase signalling networks in directed cell migration.Frontiers in cell and developmental biology · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. The Role of Rho GTPases in VEGF Signaling in Cancer Cells.Analytical cellular pathology (Amsterdam) · 2020
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Gap Junctions and Wnt Signaling in the Mammary Gland: a Cross-Talk?Journal of mammary gland biology and neoplasia · 2019
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Chronophin coordinates cell leading edge dynamics by controlling active cofilin levels.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Mirvat El-SibaiMolecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Peri Nalbant
Huan Pang
Rory J Flinn
Corina Sarmiento
Frank Macaluso
Michael Cammer
John S Condeelis
Klaus M Hahn
Jonathan M Backer
Albert Einstein College of Medicine · USUniversity of North Carolina at Chapel Hill · US

Funding

STRUCTUREU54GM064346 · NIGMS · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI IMPERIALI, BARBARA · 2001 to 2010
$74.9M
Tumor Progression and MetastasisP01CA100324 · NCI · YESHIVA UNIVERSITY · PI CONDEELIS, JOHN S · 2003 to 2018
$30.0M
P85/P110 PI 3 KINASE--STRUCTURE/FUNCTION AND PHYSIOLOGYR01GM055692 · NIGMS · YESHIVA UNIVERSITY · PI BACKER, JONATHAN M. · 1997 to 2013
$4.4M
FLUORESCENT INDICATORS OF RHO AND RAN NUCLEOTIDE STATER01GM057464 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAHN, KLAUS M. · 1999 to 2011
$3.5M
FLUORESCENT INDICATORS OF RHO AND RAN NUCLEOTIDE STATER55GM057464 · NIGMS · SCRIPPS RESEARCH INSTITUTE · PI HAHN, KLAUS MICHAEL · 1998 to 1998
–
NCI NIH HHS CA100324NCI NIH HHS P01 CA100324NIGMS NIH HHS GM057464NIGMS NIH HHS GM064346NIGMS NIH HHS R01 GM055692NIGMS NIH HHS R01 GM057464NIGMS NIH HHS U54 GM064346
6 · The paper itself

Abstract

Cdc42 plays a central role in regulating the actin cytoskeleton and maintaining cell polarity. Here, we show that Cdc42 is crucial for epidermal growth factor (EGF)-stimulated protrusion in MTLn3 carcinoma cells. When stimulated with EGF, carcinoma cells showed a rapid increase in activated Cdc42 that is primarily localized to the protruding edge of the cells. siRNA-mediated knockdown of Cdc42 expression caused a decrease in EGF-stimulated protrusion and reduced cell motility in time-lapse studies. These changes were correlated with a decrease in barbed-end formation and Arp2/3 localization at the cell edge, and a marked defect in actin filament branching, as revealed by rotary-shadowing scanning electron microscopy. Upstream of Arp2/3, Cdc42 knockdown inhibited EGF-stimulated activation of PI 3-kinase at early (within 1 minute) but not late (within 3 minutes) time points. Membrane targeting of N-WASP, WAVE2 and IRSp53 were also inhibited. Effects on WAVE2 were not owing to Rac1 inhibition, because WAVE2 recruitment is unaffected by Rac1 knockdown. Our data suggest that Cdc42 activation is crucial for the regulation of actin polymerization in carcinoma cells, and required for both EGF-stimulated protrusion and cell motility independently of effects on Rac.

Indexed as

Actin-Related Protein 2-3 ComplexActinsAdaptor Proteins, Signal TransducingAnimalsCarcinomacdc42 GTP-Binding ProteinCell Line, TumorCell MovementCell Surface ExtensionsEnzyme ActivationEpidermal Growth FactorNerve Tissue ProteinsPhosphatidylinositol 3-KinasesPhosphatidylinositol Phosphatesrac GTP-Binding Proteinsras ProteinsActin-Related Protein 2-3 ComplexActinsAdaptor Proteins, Signal TransducingBaiap2 protein, ratcdc42 GTP-Binding ProteinEpidermal Growth FactorNerve Tissue Proteinsphosphatidylinositol 3,4,5-triphosphatePhosphatidylinositol 3-KinasesPhosphatidylinositol Phosphatesrac GTP-Binding Proteinsras ProteinsRecombinant Fusion ProteinsRNA, Small InterferingTropomyosin

Identifiers

PMID17855387
PMCPMC4066376
OpenAlexW2129393642

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.